Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Heartbeam Inc (BEAT)

Heartbeam Inc (BEAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 52,954
  • Shares Outstanding, K 40,117
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,450 K
  • EBIT $ -21 M
  • EBITDA $ -21 M
  • 60-Month Beta -0.80
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 120.85

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.13
  • Number of Estimates 2
  • High Estimate -0.10
  • Low Estimate -0.16
  • Prior Year -0.18
  • Growth Rate Est. (year over year) +27.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2720 +3.77%
on 02/11/26
2.6000 -49.23%
on 01/12/26
-1.0800 (-45.00%)
since 01/09/26
3-Month
0.5400 +144.44%
on 11/21/25
4.0000 -67.00%
on 12/17/25
-0.4000 (-23.26%)
since 11/11/25
52-Week
0.5400 +144.44%
on 11/21/25
4.0000 -67.00%
on 12/17/25
-0.9700 (-42.36%)
since 02/11/25

Most Recent Stories

More News
HeartBeam (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer

HeartBeam (NASDAQ: BEAT), a medical technology company focused on advancing cardiac care through actionable cardiac insights, announced the appointment of Bryan Humbarger as chief commercial officer,...

BEAT : 1.3200 (unch)
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer

Brings more than 25 years of experience in building and scaling groundbreaking cardiovascular technologies Will initially focus on launching the Company’s...

BEAT : 1.3200 (unch)
FDA Clearance for HeartBeam (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup

HeartBeam (NASDAQ: BEAT) was among the medical device companies highlighted in a Jan. 8 report by Modern Healthcare by Lauren Dubinsky that outlined FDA clearances and approvals across the medical device...

BEAT : 1.3200 (unch)
HeartBeam (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through advanced cardiac insights, announced that it will attend the JP Morgan 2026 Annual Healthcare Conference...

JPM : 310.82 (-2.34%)
BEAT : 1.3200 (unch)
HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference

HeartBeam Recently Received US Food and Drug Administration (FDA) Clearance for First-Ever Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment ...

BEAT : 1.3200 (unch)
HeartBeam (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation

HeartBeam (NASDAQ: BEAT), a medical-technology company developing advanced electrocardiogram solutions, was featured in a recent article that discussed its recognition as a Global IP and Technology Leader...

BEAT : 1.3200 (unch)
HeartBeam (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) clearance for its 12-lead ECG synthesis software for arrhythmia...

BEAT : 1.3200 (unch)
HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment

FDA Clearance Granted After Successful Appeal, Overturning Prior Not Substantially Equivalent (NSE) Outcome HeartBeam’s Credit-Card Sized Device Delivers...

BEAT : 1.3200 (unch)
HeartBeam (NASDAQ: BEAT) Outlines Regulatory Strategy After NSE Decision on ECG Synthesis Software

HeartBeam (NASDAQ: BEAT), a medical technology company developing personalized cardiac-care insights, detailed its strategy following receipt of a Not Substantially Equivalent decision for its 510(k) submission...

BEAT : 1.3200 (unch)
HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application

Company engaging in multiple options for a constructive resolution Strategy is underpinned by a clinical study that achieved the agreed upon endpoints...

BEAT : 1.3200 (unch)

Business Summary

HeartBeam Inc. is a development stage digital healthcare company with proprietary ECG telemedicine technology. HeartBeam Inc. is based in SANTA CLARA, Calif.

See More

Key Turning Points

3rd Resistance Point 1.4840
2nd Resistance Point 1.4320
1st Resistance Point 1.3760
Last Price 1.3200
1st Support Level 1.2680
2nd Support Level 1.2160
3rd Support Level 1.1600

See More

52-Week High 4.0000
Fibonacci 61.8% 2.6783
Fibonacci 50% 2.2700
Fibonacci 38.2% 1.8617
Last Price 1.3200
52-Week Low 0.5400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar